Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005890 · ClinicalTrials.gov registry record · NA
Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock
A NA study of Septic Shock, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT00005890 is a NA study of Septic Shock that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 56 participants, below the 5,057-participant average among 24 other Septic Shock trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00005890, a NA study of Septic Shock, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
OBJECTIVES: I. Examine adrenal cortical function and the incidence of adrenal dysfunction in children with septic shock. II. Examine the mortality, length of stay in the PICU, and incidence of multiorgan failure in children with adrenal dysfunction and septic shock.
Conditions Studied
Interventions
- DRUG corticotropin
Study Locations (1)
Ohio
- Children's Hospital Medical Center - Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 1996-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005890
The ClinicalTrials.gov registry entry for NCT00005890 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,057-participant average among 24 other Septic Shock trials with a reported enrollment target (99% lower). The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Septic Shock appearing as the primary indexed condition, and to 1 intervention - of which corticotropin is the first listed.
NCT00005890 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00005890 about?
NCT00005890 is a clinical study titled "Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock". OBJECTIVES: I. Examine adrenal cortical function and the incidence of adrenal dysfunction in children with septic shock. II. Examine the mortality, length of stay in the PICU, and incidence of multiorgan failure in children with adrenal dysfunction and septic shock.
What is the current status of trial NCT00005890?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 1996-03.
What conditions does trial NCT00005890 study?
This clinical trial studies the following conditions: Septic Shock.
What interventions are being tested in trial NCT00005890?
The interventions under investigation include: corticotropin (DRUG).
Who is sponsoring clinical trial NCT00005890?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00005890 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Septic Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
RECRUITING · NA
-
Assessment for Implementation Methods in Sepsis
RECRUITING · NA
-
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
RECRUITING · NA
-
Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study
ACTIVE NOT RECRUITING · NA
-
Blood Purification for the Treatment of Pathogen Associated Shock
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.